The Role of Adjuvant Radiotherapy for Early‐Stage Oral Cavity Cancer With Minor Adverse Features; A Single Institute Experience
Head & Neck · 2025
DOI: 10.1002/hed.28093 ↗At a glance
Journal article in Head & Neck, 2025. Written by Eyal Yosefof and 6 co-authors. Institution: Department of Otolaryngology Head and Neck Surgery, Rabin Medical Center, Petah Tikva, Israel. Major MEDLINE topics: Carcinoma, Squamous Cell, Tongue Neoplasms, Mouth Neoplasms. Cited 2 times so far (Crossref); 23 references. The full text is freely available (open access, CC BY-NC 4.0).
Abstract (original language)
Background
The role of post‐operative radiotherapy (PORT) in early‐stage (T1‐T2N0M0) oral tongue squamous cell carcinoma (OTSCC) with minor adverse features (MAF) including perineural invasion (PNI) and poorly differentiated carcinoma (PDC) is not well described. We aimed to study the role of PORT among these patients.
Methods
A retrospective review of patients treated for early‐stage OTSCC between 2000 and 2022 in a tertiary‐care referral center while comparing patients treated by surgery and PORT with patients treated by surgery alone.
Results
One hundred fifty‐four patients were included and 36 (23.4%) received PORT. The PORT subgroup had a significantly higher rate of MAF. Survival rates were similar between the two sub‐groups. PORT demonstrated a trend toward improved overall survival (odds ratio = 0.406, p = 0.07). Patients with PNI or PDC treated with PORT experienced improved survival rates.
Conclusion
PORT has an important role when treating early‐stage OTSCC with MAF. It should be considered especially among patients with PNI or PDC.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Otolaryngology Head and Neck Surgery, Rabin Medical Center, Petah Tikva, Israel.
- Institute of Oncology, Davidoff Center, Rabin Medical Center, Petach Tikva, Israel.
- Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
- Sharett Institute of Oncology, Hadassah Hebrew University Medical Center, Jerusalem, Israel.
ORCID profiles: Eyal Yosefof, Nofar Edri
Cite
APA
Yosefof, E., Edri, N., Kurman, N., Bachar, G., Shpitzer, T., Mizrachi, A., & Popovtzer, A. (2025). The Role of Adjuvant Radiotherapy for Early‐Stage Oral Cavity Cancer With Minor Adverse Features; A Single Institute Experience. Head & Neck. https://doi.org/10.1002/hed.28093
Vancouver
Yosefof E, Edri N, Kurman N, Bachar G, Shpitzer T, Mizrachi A, et al. The Role of Adjuvant Radiotherapy for Early‐Stage Oral Cavity Cancer With Minor Adverse Features; A Single Institute Experience. Head & Neck. 2025. doi:10.1002/hed.28093
BibTeX
@article{Yosefof2025,
author = {Yosefof, Eyal and Edri, Nofar and Kurman, Noga and Bachar, Gideon and Shpitzer, Thomas and Mizrachi, Aviram and Popovtzer, Aron},
title = {The Role of Adjuvant Radiotherapy for Early‐Stage Oral Cavity Cancer With Minor Adverse Features; A Single Institute Experience},
journal = {Head & Neck},
year = {2025},
doi = {10.1002/hed.28093}
}
EUVIMED